Treatment Buddies Improve Clinic Attendance among Women but Not Men on Antiretroviral Therapy in the Nyanza Region of Kenya

Table 3

Adjusted relative risks for factors associated with clinic attendance during the first six months on ART, by gender.

Predictor	Male ()					Female ()
		% attended	aRR	95% CI	value		% attended	aRR	95% CI	value
Has treatment buddy
Yes	679	57.6	1.01	0.76–1.32	0.97	1243	60.6	1.28	1.08–1.53	0.005
No	37	59.5	REF			162	45.1	REF
Age
15–29	173	56.7	REF			681	54.9	REF
30–44	394	56.6	0.99	0.85–1.15	0.90	599	62.4	1.12	1.03–1.22	0.01
45+	149	61.7	1.05	0.87–1.25	0.62	125	62.4	1.14	0.98–1.33	0.08
Marital status
Single	191	53.9	REF			798	54.0	REF
Partnered	525	59.1	1.02	0.89–1.18	0.75	607	65.1	1.10	1.01–1.20	0.04
Year ART initiated
2007	6	16.7	0.20	0.03–1.24	0.08	26	42.3	0.62	0.39–0.99	0.04
2008	78	59.0	0.83	0.66–1.03	0.09	151	54.3	0.80	0.68–0.94	0.007
2009	163	60.7	0.97	0.82–1.14	0.71	318	53.8	0.83	0.73–0.94	0.003
2010	245	57.1	0.90	0.77–1.05	0.17	479	61.0	0.94	0.85–1.04	0.24
2011	224	56.7	REF			431	62.7	REF
Months from engagement in care to ART initiation
<1	354	52.5	REF			581	58.5	REF
1-2	188	60.6	1.07	0.92–1.23	0.37	315	55.9	0.92	0.82–1.04	0.18
2-3	42	61.9	1.12	0.85–1.48	0.40	96	51.0	0.88	0.72–1.08	0.21
>3	132	65.9	1.12	0.94–1.32	0.20	413	63.2	1.04	0.93–1.16	0.45
CD4 count
>350	38	65.8	1.09	0.84–1.40	0.51	115	56.5	0.92	0.77–1.09	0.32
200–350	214	63.1	1.04	0.90–1.20	0.61	565	63.4	1.05	0.95–1.16	0.36
<200	464	54.5	REF			725	55.6	REF
WHO stage
1	151	67.6	REF			365	66.0	REF
2	194	61.9	0.93	0.80–1.09	0.36	506	58.1	0.91	0.83–1.01	0.09
3	308	51.3	0.80	0.69–0.93	0.003	454	57.1	0.91	0.81–1.01	0.08
4	62	51.6	0.74	0.57–0.96	0.03	80	40.0	0.65	0.49–0.85	0.002
Clinic site
Lumumba	345	72.5	REF			577	71.4	REF
Tuungane	22	45.5	0.58	0.36–0.92	0.02	41	31.7	0.44	0.28–0.69	0.0003
PandiPieri	349	43.8	0.58	0.51–0.67	<0.0001	610	52.3	0.69	0.63–0.76	<0.0001
FHOK	na	na	na	na	na	177	46.3	0.68	0.57–0.81	<0.0001